That was my basic understanding as well. The claims in these kinds of press releases would be particularly scrutinized by, e.g. the SEC, FDA, etc..
I hadn’t known until I met someone that did it, but many (basically all?) companies have investor relations personnel or consultants. I know that some of those IR people also specialize in pharmaceutical or biomedical companies. They would definitely be involved in writing these kinds of press releases too.
That was my basic understanding as well. The claims in these kinds of press releases would be particularly scrutinized by, e.g. the SEC, FDA, etc..
I hadn’t known until I met someone that did it, but many (basically all?) companies have investor relations personnel or consultants. I know that some of those IR people also specialize in pharmaceutical or biomedical companies. They would definitely be involved in writing these kinds of press releases too.